Angelini Pharma in Sweden
Angelini Pharma established itself in the Nordic countries in early 2022 with its headquarters centrally located in Stockholm. The company has around 20 employees working in the field of neurology. We aim to challenge the prevailing views on how best to treat diseases. We are convinced that a combination of treatment and medication, along with collaboration and exchange of experiences with patients, relatives, healthcare professionals, and decision-makers, are important components for reducing suffering. Bringing together and stimulating the exchange of thoughts, experiences, and ideas is particularly important to improve the situation for people whose lives are affected by severe illness.
With Angelini Pharma now established in Sweden and the Nordic region, it is ensured that patients with severe forms of epilepsy have access to an additional treatment option.
Medications
We have the following medications in Sweden:
